Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches BioNTech aims to develop BNT327/PM8002 as a next-genera ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

BioNTech already owned part of InstaDeep as ... hub in Asia – located initially in Taiwan – along with an mRNA manufacturing unit in Singapore, according to the company's JPM update.

BioNTech may be deeply ensconced in the latter ... protein engineering, manufacturing and supply chain. One of the main research areas for the new lab will be the development of new vaccines ...

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half ...

BioNTech is a Germany-based biotechnology ... selling primarily to electric arc furnace steel mills, foundries for manufacturing process, nonferrous scrap metal to aluminum can producers ...

The GBA has not only mirrored the nation's transformation from a world factory to a smart manufacturing hub, but has also incubated 70 unicorn companies — startups valued at over $1 billion each.